ZTS · NYSE
Zoetis (ZTS) Stock Price & Fundamentals
Zoetis (ZTS) closed at $560.97 on Oct 9, 2026, up 0.62% from the previous close of $557.52.
Share price, past year
1Y +55.02%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $560.97 |
| Sep 30, 2026 | $557.49 |
| Aug 31, 2026 | $555.72 |
| Jul 31, 2026 | $558.19 |
| Jun 30, 2026 | $540.03 |
| May 29, 2026 | $487.62 |
| Apr 30, 2026 | $486.28 |
| Mar 31, 2026 | $483.70 |
| Feb 27, 2026 | $446.41 |
| Jan 30, 2026 | $460.26 |
| Dec 31, 2025 | $437.76 |
| Nov 28, 2025 | $402.82 |
| Oct 31, 2025 | $377.79 |
Key statistics
- Market cap
- $232.33B
- P/E (TTM)
- 91.7
- EPS (TTM)
- $6.12
- Revenue (TTM)
- $9.53B
- Net income (TTM)
- $2.64B
- Shares outstanding
- 414.2M
- Dividend yield
- —
- 52-week range
- $358.31 – $572.18
Zoetis's market cap is $232.33B, based on a share price of $560.97 and 414.2M shares outstanding as of Jun 30, 2026.
Financials
Zoetis reported revenue of $9.47B for fiscal 2025, up 2.28% from fiscal 2024.
Zoetis earned net income of $2.67B in fiscal 2025, a net margin of 28.2%.
Fiscal 2025 revenue was the highest in the 10 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $9.47B | +2.3% | $2.67B | 28.2% | $6.02 | $2.28B |
| FY2024ended Dec 31, 2024 | $9.26B | +8.3% | $2.49B | 26.9% | $5.47 | $2.30B |
| FY2023ended Dec 31, 2023 | $8.54B | +5.7% | $2.34B | 27.4% | $5.07 | $1.62B |
| FY2022ended Dec 31, 2022 | $8.08B | +3.9% | $2.11B | 26.2% | $4.49 | $1.33B |
| FY2021ended Dec 31, 2021 | $7.78B | +16.5% | $2.04B | 26.2% | $4.27 | $1.74B |
| FY2020ended Dec 31, 2020 | $6.68B | +6.6% | $1.64B | 24.5% | $3.42 | $1.67B |
| FY2019ended Dec 31, 2019 | $6.26B | +7.5% | $1.50B | 24.0% | $3.11 | $1.34B |
| FY2018ended Dec 31, 2018 | $5.83B | +9.8% | $1.43B | 24.5% | $2.93 | $1.45B |
| FY2017ended Dec 31, 2017 | $5.31B | +8.6% | $864.00M | 16.3% | $1.75 | $1.12B |
| FY2016ended Dec 31, 2016 | $4.89B | — | $821.00M | 16.8% | $1.65 | $497.00M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $2.47B | $691.00M | $1.65 |
| Q1 FY2026ended Mar 31, 2026 | $2.26B | $601.00M | $1.42 |
| Q4 FY2025ended Dec 31, 2025 | $2.40B | $624.00M | $1.42 |
| Q3 FY2025ended Sep 30, 2025 | $2.40B | $721.00M | $1.63 |
| Q2 FY2025ended Jun 30, 2025 | $2.47B | $726.00M | $1.63 |
| Q1 FY2025ended Mar 31, 2025 | $2.20B | $602.00M | $1.34 |
| Q4 FY2024ended Dec 31, 2024 | $2.32B | $581.00M | $1.29 |
| Q3 FY2024ended Sep 30, 2024 | $2.39B | $682.00M | $1.50 |
Company profile
- Name
- Zoetis Inc.
- Ticker
- ZTS
- Exchange
- NYSE
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 10 Sylvan Way, Parsippany, NJ 07054
- Fiscal year ends
- December
- SEC CIK
- 0001555280
Recent SEC filings
- Oct 8, 2026
- Aug 6, 2026
- Aug 6, 2026
- Aug 6, 2026
- May 22, 2026
- May 20, 2026
- May 7, 2026
- May 7, 2026
Frequently asked questions
What is Zoetis's stock price?
Zoetis (ZTS) closed at $560.97 on Oct 9, 2026, up 0.62% from the previous close of $557.52.
What is Zoetis's market cap?
Zoetis's market cap is $232.33B, based on a share price of $560.97 and 414.2M shares outstanding as of Jun 30, 2026.
How much revenue does Zoetis make?
Zoetis reported revenue of $9.47B for fiscal 2025, up 2.28% from fiscal 2024.
What is ZTS's P/E ratio?
Zoetis's price-to-earnings ratio is 91.7, based on trailing twelve-month diluted EPS of $6.12.
Does Zoetis pay a dividend?
Zoetis's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Zoetis Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures